Implications of Matched Adjusted Indirect Treatment Comparisons in Rare Disease

June 2, 2021

Back to all webinars

Open to all ISPOR Members and Non-members


Presented by:
  • Shirley Liao
  • Crystal M. Proud

June 2, 2021
1:00PM EDT | 6:00PM BST | 7:00PM CEST 

Click here for time zone conversion

A one-hour educational webinar on the implications of matched adjusted indirect treatment comparisons in rare disease, using SMA as an example. Webinar will provide both statistical and clinical perspective.
 

Learning Objectives:

  • Quantitatively illustrate how results of matched adjusted indirect comparisons can be influenced by confounding factors using example from infantile-onset SMA
  • Understand importance and implications of well-conducted indirect treatment comparisons for clinical practice in rare disease. 

Register Here


Sponsored by: Biogen 

Presenters:

Shirley Liao,
PhD, Senior Biostatistician, Biogen, Cambridge, MA, USA

Crystal M. Proud, MD, Pediatric Neuromuscular Neurologist, Children’s Hospital of The King’s Daughters, Norfolk, VA, USA

Please note: On the day of the scheduled webinar, the first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 weeks after the scheduled Webinar.

Reservations are on a first-come, first-served basis.

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×